TY  - JOUR
T1  - Is Your Diet to Blame? Unveiling the Role of Dietary Inflammatory Index in Lipid Accumulation Product Index and Visceral Adiposity Index in Polycystic Ovary Syndrome
TT  - Diyetiniz Suçlu Olabilir Mi? Polikistik Over Sendromunda Diyet İnflamatuar İndeksinin, Lipid Birikim Ürünü İndeksi ve Visseral Adipozite İndeksi Üzerindeki Rolünün İncelenmesi
AU  - Dumlu Bilgin, Gözde
AU  - Cengiz Pala, Gizem
PY  - 2025
DA  - August
Y2  - 2025
DO  - 10.25048/tudod.1682642
JF  - Turkish Journal of Diabetes and Obesity
JO  - Turk J Diab Obes
PB  - Zonguldak Bulent Ecevit University
WT  - DergiPark
SN  - 2587-0335
SP  - 224
EP  - 228
VL  - 9
IS  - 2
LA  - en
AB  - Aim: The present study sought to examine how the Dietary Inflammatory Index (DII) is related to different adiposity indices in womendiagnosed with polycystic ovary syndrome (PCOS).Material and Methods: The study enrolled sixty-two women aged 18 - 44 years who applied to a PCOS outpatient clinic in Istanbul.Sociodemographic data, anthropometric measurements, 3-day food records for calculating DII, and retrospective data on high-densitylipoprotein (HDL) cholesterol levels and triglyceride (TG) for adiposity indices were collected. Visceral Adiposity Index (VAI) and LipidAccumulation Product (LAP) were computed based on the obtained anthropometric data and specified blood parameters. Since thedata were divided into low and high DII groups, the Mann-Whitney U test was employed based on the statistical distribution to evaluategroup differences between continuous variables.Results: The mean age of women was 26.3 ± 6.1 years, with a body mass index (BMI) of 25.1 ± 5.9 kg/m², and 35.5% were overweight orobese. The median DII value was 1.5. Although women with high DII had higher VAI and LAP values, the difference was not statisticallysignificant. Additionally, women with high DII had significantly reduced dietary intakes of protein, total fiber, omega-3 fatty acids,monounsaturated fatty acids (MUFAs), vitamins A, K, and B vitamins (except B12), vitamin C, iron, calcium, zinc, potassium, andmagnesium.Conclusion: These findings suggest that diet-induced inflammation may contribute to metabolic disturbances in PCOS, emphasizingthe importance of anti-inflammatory dietary approaches in managing the condition.
KW  - Polycystic ovary syndrome
KW  - dietary inflammatory index
KW  - visceral adiposity index
KW  - lipid accumulation product
KW  - adiposity indices
N2  - Amaç: Bu çalışma, polikistik over sendromu (PKOS) olan kadınlarda Diyet İnflamatuar İndeksi’nin (Dİİ) çeşitli adipozite indeksleriyleilişkisini incelemeyi amaçlamıştır.Gereç ve Yöntemler: Çalışmaya, İstanbul'da bir PKOS polikliniğine başvuran 18 - 44 yaş arası altmış iki kadın dahil edildi. Sosyodemografikveriler, antropometrik ölçümler, Dİİ'yi hesaplamak için 3 günlük besin tüketim kaydı ve adipozite indeksleri için yüksek yoğunluklulipoprotein (HDL) kolesterol ve trigliserit (TG) düzeylerine ilişkin retrospektif veriler toplandı. Visseral Adipozite İndeksi (VAI) ve LipidBirikim Ürünü (LAP) indeksi, elde edilen antropometrik verilere ve belirtilen kan parametrelerine dayanarak hesaplandı. Veriler, düşükve yüksek Dİİ gruplarına ayrıldığından, sürekli değişkenler arasındaki grup farklarını değerlendirmek amacıyla, verilerin dağılımınabağlı olarak Mann-Whitney U testi uygulanmıştır.Bulgular: Kadınların ortalama yaşı 26,3 ± 6,1 yıl, beden kütle indeksi (BKİ) 25,1 ± 5,9 kg/m² idi ve %35,5'i fazla kilolu veya obezdi.Medyan Dİİ değeri 1,5'ti. Yüksek Dİİ'li kadınların daha yüksek VAI ve LAP değerleri olmasına rağmen fark, istatistiksel olarak anlamlıdeğildi. Bunun yanı sıra, yüksek Dİİ'li kadınların protein, toplam lif, omega-3 yağ asitleri, tekli doymamış yağ asitleri (TDYA), A, K ve Bvitaminleri (B12 hariç), C vitamini, demir, kalsiyum, çinko, potasyum ve magnezyum alımları anlamlı olarak daha düşüktü.Sonuç: Bu bulgular, diyet kaynaklı inflamasyonun PKOS'ta metabolik bozukluklara katkıda bulunabileceğini düşündürmekte vehastalığın yönetiminde anti-inflamatuar diyet yaklaşımlarının önemini vurgulamaktadır.
CR  - 1. Deswal R, Narwal V, Dang A, Pundir CS. The Prevalence
of Polycystic Ovary Syndrome: A Brief Systematic Review. J
Hum Reprod Sci. 2020;13(4):261–71.
CR  - 2. Salari N, Nankali A, Ghanbari A, Jafarpour S, Ghasemi H,
Dokaneheifard S, et al. Global prevalence of polycystic ovary
syndrome in women worldwide: a comprehensive systematic
review and meta-analysis. Arch Gynecol Obstet [Internet].
2024;310(3):1303–14. Available from: https://doi.org/10.1007/
s00404-024-07607-x
CR  - 3. Wang Q, Lang J, Zhi Y, Zhu X, Fu Y. Predicting factors of
ovarian responses in infertile women with polycystic ovary
syndrome undergoing IVF / ICSI. J Assist Reprod Genet [Internet].
2025; Available from: https://doi.org/10.1007/s10815-
024-03386-1
CR  - 4. Naghshband Z, Kumar L, Mandappa S, Niranjana Murthy
AS, Malini SS. Visceral adiposity index and lipid accumulation
product as diagnostic markers of metabolic syndrome in
South Indians with polycystic ovary syndrome. J Hum Reprod
Sci. 2021;14(3):234–43.
CR  - 5. Zhuang S, Jing C, Yu L, Ji L, Liu W, Hu X. The relationship
between polycystic ovary syndrome and infertility: a bibliometric
analysis. Ann Transl Med. 2022;10(6):318–318.
CR  - 6. Barber TM, McCarthy MI, Wass JAH, Franks S. Obesity
and Polycystic Ovary Syndrome. Clin Endocrinol (Oxf).
2006;65(2):137–45.
CR  - 7. Oh JY, Sung YA, Lee HJ. The visceral adiposity index as a predictor
of insulin resistance in young women with polycystic
ovary syndrome. Obesity. 2013;21(8):1690–4.
CR  - 8. Khanna D, Peltzer C, Kahar P, Parmar MS. Body Mass Index
(BMI): A Screening Tool Analysis. Cureus. 2022;14(1994):1–6.
CR  - 9. Nascimento JXPT, Chein MBDC, De Sousa RML, Ferreira
ADS, Navarro PA, Brito LMO. Importance of lipid accumulation
product index as a marker of CVD risk in PCOS women.
Lipids Health Dis [Internet]. 2015;14(1):1–8. Available from:
http://dx.doi.org/10.1186/s12944-015-0061-y
CR  - 10. Kahn HS. The “lipid accumulation product” performs better
than the body mass index for recognizing cardiovascular risk:
A population-based comparison. BMC Cardiovasc Disord.
2005;5:1–10.
CR  - 11. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S,
Midiri M, et al. Visceral adiposity index: A reliable indicator
of visceral fat function associated with cardiometabolic risk.
Diabetes Care. 2010;33(4):920–2.
CR  - 12. Anik Ilhan G, Yildizhan B, Pekin T. The impact of lipid accumulation
product (LAP) and visceral adiposity index (VAI) on
clinical, hormonal and metabolic parameters in lean women
with polycystic ovary syndrome. Gynecol Endocrinol [Internet].
2019;35(3):233–6. Available from: https://doi.org/10.108
0/09513590.2018.1519794
CR  - 13. Durmus U, Duran C, Ecirli S. Visceral adiposity index levels
in overweight and/or obese, and non-obese patients with
polycystic ovary syndrome and its relationship with metabolic
and inflammatory parameters. J Endocrinol Invest.
2017;40(5):487–97.
CR  - 14. Wiltgen D, Benedetto IG, Mastella LS, Spritzer PM. Lipid
accumulation product index: A reliable marker of cardiovascular
risk in polycystic ovary syndrome. Hum Reprod.
2009;24(7):1726–31.
CR  - 15. Aboeldalyl S, James C, Seyam E, Ibrahim EM, Shawki HED,
Amer S. The role of chronic inflammation in polycystic ovarian
syndrome—a systematic review and meta-analysis. Int J
Mol Sci. 2021;22(5):1–31.
CR  - 16. Clemente-Suárez VJ, Beltrán-Velasco AI, Redondo-Flórez L,
Martín-Rodríguez A, Tornero-Aguilera JF. Global Impacts
of Western Diet and Its Effects on Metabolism and Health: A
Narrative Review. Nutrients. 2023;15(12).
CR  - 17. Tsigalou C, Konstantinidis T, Paraschaki A, Stavropoulou E,
Voidarou C, Bezirtzoglou E. Mediterranean diet as a tool to
combat inflammation and chronic diseases. An overview. Biomedicines.
2020;8(8):1–13.
CR  - 18. Shivappa N, Steck SE, Hurley TG, Hussey JR, Hébert JR.
Designing and developing a literature-derived, population-
based dietary inflammatory index. Public Health Nutr.
2014;17(8):1689–96.
CR  - 19. Mtintsilana A, Micklesfield LK, Chorell E, Olsson T, Shivappa
N, Hebert JR, et al. Adiposity mediates the association between
the dietary inflammatory index and markers of type 2
diabetes risk in middle-aged black South African women. Nutrients.
2019;11(6):1–19.
CR  - 20. Saghafi-Asl M, Mirmajidi S, Asghari Jafarabadi M, Vahid F,
Shivappa N, Hébert JR, et al. The association of dietary patterns
with dietary inflammatory index, systemic inflammation,
and insulin resistance, in apparently healthy individuals with
obesity. Sci Rep [Internet]. 2021;11(1):1–8. Available from:
https://doi.org/10.1038/s41598-021-86993-7
CR  - 21. Rahimlou M, Ahmadi AR, Cheraghian B, Baghdadi G, Ghalishourani
SS, Nozarian S, et al. The association between dietary
inflammatory index with some cardio-metabolic risk indices
among the patients with type 2 diabetes from Hoveyzeh
cohort study: a cross-sectional study. BMC Endocr Disord.
2024;24(1):1–12.
CR  - 22. Zirak Sharkesh E, Keshavarz SA, Nazari L, Abbasi B. The dietary
inflammatory index is directly associated with polycystic
ovary syndrome: A case-control study. Clin Endocrinol (Oxf).
2022;96(5):698–706.
CR  - 23. Yousefi Rad E, Kavei P, Akbari S, Vahid F, Hebert JR, Falahi E,
et al. Association between Dietary Inflammatory Index (DII)
and the Risk of Polycystic Ovary Syndrome: A Case-Control
Study. J Nutr Food Secur. 2024;9(2):214–22.
CR  - 24. Alissa EM, Algarni SA, Khaffji AJ, Al Mansouri NM. Association
of diet diversity score with visceral adiposity in women
with polycystic ovarian syndrome. Hum Nutr Metab [Internet].
2021;23:200116. Available from: https://doi.org/10.1016/j.
hnm.2020.200116
CR  - 25. Bilginer MC, Tüfekçi D, Emur Günay Y, Usta O, Coşkun H,
Üçüncü O, et al. Evaluation of Insulin Resistance Measurement
Methods in Patients with Polycystic Ovary Syndrome.
Turkish J Diabetes Obes. 2022;6(1):24–31.
CR  - 26. European Society of Human Reproduction and Embryology.
Revised 2003 consensus on diagnostic criteria and long-term
health risks related to polycystic ovary syndrome. Hum Reprod.
2004;19(1):41–7.
CR  - 27. World Health Organization Regional Office for Europe. Body
mass index - BMI [Internet]. [cited 2021 Feb 10]. Available
from: https://www.euro.who.int/en/health-topics/disease-
prevention/nutrition/a-healthy-lifestyle/body-mass-index-
bmi#
CR  - 28. Cavicchia PP, Steck SE, Hurley TG, Hussey JR, Ma Y, Ockene
IS, et al. A new dietary inflammatory index predicts interval
changes in serum high-sensitivity C-reactive protein. J Nutr.
2009;139(12):2365–72.
CR  - 29. Rakıcıoğlu N, Tek N, Ayaz A, Pekcan A. Yemek ve Besin
Fotoğraf Kataloğu Ölçü ve Miktarlar. Ankara: Ata Ofset Matbaacılık;
2010.
CR  - 30. Kutluay Merdol T. Toplu beslenme yapılan kurumlar için
standard yemek tarifleri. Ankara: Hatipoğlu Yayınları; 2003.
CR  - 31. Adanaş Aydın G, Özgen G. The relation of visceral adiposity
index and lipid accumulation product with metabolic, anthropometric,
and hormonal parameters in patients with polycystic
ovary syndrome. J Surg Med. 2020;4(8):664–8.
CR  - 32. Gönülalan G, Saçkan F. The Importance of New Anthropometric
Measurements in Detecting Cardio Metabolic Risk
and Insulin Resistance in Patients with Polycystic Ovary Syndrome:
Single Center Experience. Turkish J Diabetes Obes.
2021;5(1):25–32.
CR  - 33. Shreenidhi RA, Mahey R, Rajput M, Cheluvaraju R, Upadhyay
AD, Sharma JB, et al. Utility of Visceral Adiposity Index and
Lipid Accumulation Products to Define Metabolically-Unhealthy
Polycystic Ovary Syndrome in Asian Indian Women
- A Cross Sectional Study. J Hum Reprod Sci. 2024;17(1):50–7.
CR  - 34. Mario FM, Graff SK, Spritzer PM. Adiposity Indexes as Phenotype-
Specific Markers of Preclinical Metabolic Alterations
and Cardiovascular Risk in Polycystic Ovary Syndrome:
A Cross-Sectional Study. Exp Clin Endocrinol Diabetes.
2017;125(5):307–15.
CR  - 35. Alenezi SA, Elkmeshi N, Alanazi A, Alanazi ST, Khan R, Amer
S. The Impact of Diet-Induced Weight Loss on Inflammatory
Status and Hyperandrogenism in Women with Polycystic
Ovarian Syndrome (PCOS)—A Systematic Review and Meta-
Analysis. J Clin Med. 2024;13(16).
CR  - 36. Wang Q, Sun Y, Xu Q, Liu W, Wang P, Yao J, et al. Higher dietary
inflammation potential and certain dietary patterns are
associated with polycystic ovary syndrome risk in China: A
case-control study. Nutr Res [Internet]. 2022;100:1–18. Available
from: https://doi.org/10.1016/j.nutres.2021.12.006
CR  - 37. Azarbayjani K, Jahanian Sadatmahalleh S, Mottaghi A, Nasiri
M. Association of dietary inflammatory index with C-reactive
protein and interleukin-6 in women with and without polycystic
ovarian syndrome. Sci Rep [Internet]. 2024;14(1):1–10.
Available from: https://doi.org/10.1038/s41598-024-53958-5
CR  - 38. Khan I, Kwon M, Shivappa N, Hébert JR, Kim MK. Positive association
of dietary inflammatory index with incidence of cardiovascular
disease: Findings from a korean population-based
prospective study. Nutrients. 2020;12(2).
CR  - 39. Shivappa N, Hébert JR, Rietzschel ER, De Buyzere ML, Langlois
M, Debruyne E, et al. Associations between dietary inflammatory
index and inflammatory markers in the Asklepios
Study. Br J Nutr. 2015;113(4):665–71.
CR  - 40. Zaeemzadeh N, Jahanian Sadatmahalleh S, Ziaei S, Kazemnejad
A, Movahedinejad M, Mottaghi A, et al. Comparison of dietary
micronutrient intake in PCOS patients with and without
metabolic syndrome. J Ovarian Res. 2021;14(1):1–9.
CR  - 41. Kazemi M, Kim JY, Wan C, Xiong JD, Michalak J, Xavier IB,
et al. Comparison of dietary and physical activity behaviors in
women with and without polycystic ovary syndrome: a systematic
review and meta-analysis of 39 471 women. Vol. 28,
Human Reproduction Update. 2022. 910–955 p.
CR  - 42. Yuan J, Wen X, Jia M. Efficacy of omega-3 polyunsaturated
fatty acids on hormones, oxidative stress, and inflammatory
parameters among polycystic ovary syndrome: A systematic
review and meta-analysis. Ann Palliat Med. 2021;10(8):8991–
9001.
UR  - https://doi.org/10.25048/tudod.1682642
L1  - https://dergipark.org.tr/en/download/article-file/4801544
ER  -